Back to Search Start Over

No-response at mpMRI after neoadjuvant pembrolizumab is a proxy of adverse pathological and oncological outcomes in patients treated with radical cystectomy: Interim results from the PURE01 study

Authors :
M. Bandini
E. Zaffuto
S. Scuderi
F. Pederzoli
L. Marandino
D. Raggi
F. Barletta
G. Gandaglia
N. Fossati
G. Burgio
M. Moschini
S. Zamboni
L. Afferi
S. Comara
A. Briganti
F. Montorsi
R. Colombo
A. Necchi
A. Gallina
Source :
European Urology Open Science, Vol 19, Iss , Pp e823- (2020)
Publication Year :
2020
Publisher :
Elsevier, 2020.

Details

Language :
English
ISSN :
26661683
Volume :
19
Issue :
e823-
Database :
Directory of Open Access Journals
Journal :
European Urology Open Science
Publication Type :
Academic Journal
Accession number :
edsdoj.048d690cb3f544c2b0aec3247eafd0e9
Document Type :
article
Full Text :
https://doi.org/10.1016/S2666-1683(20)33132-3